article thumbnail

The European Commission report on competition enforcement in the pharmaceutical sector

JD Supra: Mergers

The report looks at enforcement from 2018 - 2022 and is a follow-up of the previous report which covered 2009 - 2017. By: Hogan Lovells

article thumbnail

Healthcare & Life Sciences Private Equity Deal Tracker: Accel-KKR Acquires VisiQuate

JD Supra: Mergers

VisiQuate, founded in 2009 and based in Santa Rosa, California, is a provider of revenue cycle management and analytics solutions for health systems. Accel-KKR has acquired VisiQuate, according to a news release. By: McGuireWoods LLP

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

JPMorgan upgrades Campbell Soup, saying its recently-acquired Rao's sauce business is thriving

CNBC: Investing

The bank now has an overweight recommendation on the stock for the first time since 2009.

Business 131
article thumbnail

Healthcare & Life Sciences Private Equity Deal Tracker: GTCR Nears Deal for Caravel Autism Health

JD Supra: Mergers

Caravel Autism Health, founded in 2009 and based in Green Bay, Wisconsin, is a provider of in-home intensive, post-intensive, pre-intensive and diagnostic evaluation services to children with autism spectrum disorder. GTCR is expected to acquire Caravel Autism Health, according to industry reports. By: McGuireWoods LLP

article thumbnail

UK house prices fall by most since 2009, higher rates to bite-Nationwide

Global Banking & Finance

UK house prices fall by most since 2009, higher rates to bite-Nationwide LONDON (Reuters) -British house prices fell by the most since 2009 in the 12 months to May and the country’s housing market faces further headwinds after a recent jump in borrowing costs, mortgage lender Nationwide said on Thursday.

52
article thumbnail

A Capital Blow for Deducting Management Expenses

JD Supra: Mergers

The decision also confirms that once a company has decided in principle to dispose of a capital asset, any professional fees incurred afterwards in pursuance of that sale are likely to be capital and not deductible under CTA 2009 s 1219, even if a purchaser for that asset has not yet been identified and a specific sale transaction has not yet.

Capital 161
article thumbnail

Antitrust & Competition Life Sciences Quarterly Update - Q2 2023

JD Supra: Mergers

The Federal Trade Commission (FTC) announced its attempt to block Amgen/Horizon, the first such challenge to a life science transaction since 2009, and issued a second request in Pfizer’s proposed $43 billion acquisition of Seagen. The second quarter saw significant enforcement and dealmaking in the life sciences space. By: Goodwin

Trading 130